Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview

Author(s): Rodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, Liang Cheng, Holger Moch, Marina Scarpelli

Journal Name: Current Drug Targets

Volume 16 , Issue 2 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


This contribution gives an overview of recent insights and emerging strategies for individualized therapeutic approaches based on genomic and cancer molecular profiles in patients with a morphological diagnosis of renal, bladder and prostate tumors. Significant advances have been made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has increased our knowledge on tumor cell biology and cancer development, thus allowing us to identify complex genomic abnormalities. These findings have paved the way to provide healthcare from an individual perspective. An emerging strategy to individualize therapeutic interventions is focused on stem cells. Because of their unique characteristics, they are among the most promising candidates as potential vectors carrying suicide genes into different types of cancer, including genitourinary tumors. Another emerging strategy could be based on prostate specific membrane antigen (PSMA), a unique membrane-bound glycoprotein, which is overexpressed manifold in prostate cancer. PSMA can serve as target for delivering therapeutic agents such as cytotoxins or radionuclides.

Keywords: Bladder cancer, beasholer cancer, genito-urinary cancers, kidney cancer, molecular pathology, personalized therapies, prostate cancer, urogenital pathology.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 01 December, 2014
Page: [96 - 102]
Pages: 7
DOI: 10.2174/1389450115666141202113805
Price: $65

Article Metrics

PDF: 55